Hyaluronic Acid-PEG-Based Diels–Alder <i>In Situ</i> Forming Hydrogels for Sustained Intraocular Delivery of Bevacizumab-Reference-Cited by-同舟云学术

Hyaluronic Acid-PEG-Based Diels–Alder In Situ Forming Hydrogels for Sustained Intraocular Delivery of Bevacizumab

Published:2022-06-23 Issue:7 Volume:23 Page:2914-2929
ISSN:1525-7797
Container-title:Biomacromolecules
language:en
Short-container-title:Biomacromolecules

Author:

Ilochonwu Blessing C.¹,Mihajlovic Marko¹^ORCID,Maas-Bakker Roel F.¹,Rousou Charis¹,Tang Miao²,Chen Mei²,Hennink Wim E.¹^ORCID,Vermonden Tina¹^ORCID

Affiliation:

1. Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Faculty of Science, Utrecht University, PO box 80082, 3508 TB Utrecht, The Netherlands

2. Wellcome-Wolfson Institute for Experimental Medicine, School of Medicine, Dentistry & Biomedical Sciences, Queen’s University, Belfast BT9 7BL, U.K.

Funder

H2020 Marie Sklodowska-Curie Actions

Publisher

American Chemical Society (ACS)

Subject

Materials Chemistry,Polymers and Plastics,Biomaterials,Bioengineering

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.biomac.2c00383

Reference93 articles.

1. World Health Organization. World Report on Vision, WHO, October 2019; p 2019.

2. Global prevalence of diabetic retinopathy: protocol for a systematic review and meta-analysis

3. Colijn, J. M.; Buitendijk, G. H.; Meester, M. A.; Vingerling, J. R.; Hofman, A.; Klaver, C. C. W.The prevalence of Age-related Macular Degeneration in Europe. The E3 Consortium. In Investigative Ophthalmology & Visual Science, 2016; Vol. 57, pp 11.